logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 3
  • 1
    Dale, Mark Christopher, Dr
    Born in May 1961
    Individual (27 offsprings)
    Officer
    2015-03-31 ~ now
    OF - Director → CIF 0
  • 2
    Khan, Imran Ahmed
    Individual (1 offspring)
    Officer
    2021-08-01 ~ now
    OF - Secretary → CIF 0
  • 3
    MAC RESEARCH LTD 07543473 09700814... (more)
    19, Park Road, Lytham St. Annes, England
    Active Corporate (7 parents, 7 offsprings)
    Person with significant control
    2016-11-12 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

MAC CLINICAL RESEARCH FINANCE LTD

Period: 2015-03-31 ~ now
Company number: 09518942
Registered name
MAC CLINICAL RESEARCH FINANCE LTD - now
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Administrative Expenses
-23,480,328 GBP2024-07-01 ~ 2025-06-30
-22,127,045 GBP2023-07-01 ~ 2024-06-30
Other Interest Receivable/Similar Income (Finance Income)
604 GBP2024-07-01 ~ 2025-06-30
30,331 GBP2023-07-01 ~ 2024-06-30
Profit/Loss on Ordinary Activities Before Tax
-2,302,840 GBP2024-07-01 ~ 2025-06-30
-1,808,769 GBP2023-07-01 ~ 2024-06-30
Profit/Loss
496,842 GBP2024-07-01 ~ 2025-06-30
880,150 GBP2023-07-01 ~ 2024-06-30
Comprehensive Income/Expense
496,842 GBP2024-07-01 ~ 2025-06-30
880,150 GBP2023-07-01 ~ 2024-06-30
Intangible Assets
Other
837,273 GBP2025-06-30
775,355 GBP2024-06-30
Property, Plant & Equipment
1,704,003 GBP2025-06-30
1,846,067 GBP2024-06-30
Fixed Assets - Investments
4,173,009 GBP2025-06-30
4,037,816 GBP2024-06-30
Fixed Assets
6,714,285 GBP2025-06-30
6,659,238 GBP2024-06-30
Debtors
10,602,383 GBP2025-06-30
10,848,085 GBP2024-06-30
Cash at bank and in hand
454 GBP2025-06-30
251 GBP2024-06-30
Current Assets
10,602,837 GBP2025-06-30
10,848,336 GBP2024-06-30
Creditors
Current, Amounts falling due within one year
-6,028,249 GBP2025-06-30
Net Current Assets/Liabilities
4,574,588 GBP2025-06-30
4,445,881 GBP2024-06-30
Total Assets Less Current Liabilities
11,288,873 GBP2025-06-30
11,105,119 GBP2024-06-30
Creditors
Non-current, Amounts falling due after one year
-668,817 GBP2024-06-30
Net Assets/Liabilities
10,531,961 GBP2025-06-30
10,053,869 GBP2024-06-30
Equity
Called up share capital
10 GBP2025-06-30
10 GBP2024-06-30
10 GBP2023-06-30
Retained earnings (accumulated losses)
10,531,951 GBP2025-06-30
10,053,859 GBP2024-06-30
9,192,459 GBP2023-06-30
Equity
10,531,961 GBP2025-06-30
10,053,869 GBP2024-06-30
Profit/Loss
Retained earnings (accumulated losses)
496,842 GBP2024-07-01 ~ 2025-06-30
880,150 GBP2023-07-01 ~ 2024-06-30
Dividends Paid
Retained earnings (accumulated losses)
-18,750 GBP2023-07-01 ~ 2024-06-30
Dividends Paid
-18,750 GBP2024-07-01 ~ 2025-06-30
Audit Fees/Expenses
23,000 GBP2024-07-01 ~ 2025-06-30
17,500 GBP2023-07-01 ~ 2024-06-30
Average Number of Employees
3852024-07-01 ~ 2025-06-30
3652023-07-01 ~ 2024-06-30
Wages/Salaries
15,995,672 GBP2024-07-01 ~ 2025-06-30
15,058,195 GBP2023-07-01 ~ 2024-06-30
Staff Costs/Employee Benefits Expense
17,795,555 GBP2024-07-01 ~ 2025-06-30
16,640,629 GBP2023-07-01 ~ 2024-06-30
Director Remuneration
18,150 GBP2024-07-01 ~ 2025-06-30
18,000 GBP2023-07-01 ~ 2024-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
11,366 GBP2024-07-01 ~ 2025-06-30
145,945 GBP2023-07-01 ~ 2024-06-30
Intangible Assets - Gross Cost
Computer software
1,091,738 GBP2025-06-30
967,351 GBP2024-06-30
Property, Plant & Equipment - Gross Cost
Improvements to leasehold property
845,812 GBP2025-06-30
536,780 GBP2024-06-30
Plant and equipment
3,906,486 GBP2025-06-30
3,746,200 GBP2024-06-30
Motor vehicles
38,499 GBP2025-06-30
20,500 GBP2024-06-30
Property, Plant & Equipment - Gross Cost
4,790,797 GBP2025-06-30
4,303,480 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Improvements to leasehold property
443,283 GBP2025-06-30
347,914 GBP2024-06-30
Plant and equipment
2,620,386 GBP2025-06-30
2,088,999 GBP2024-06-30
Motor vehicles
23,125 GBP2025-06-30
20,500 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
3,086,794 GBP2025-06-30
2,457,413 GBP2024-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Improvements to leasehold property
95,369 GBP2024-07-01 ~ 2025-06-30
Plant and equipment
531,387 GBP2024-07-01 ~ 2025-06-30
Motor vehicles
2,625 GBP2024-07-01 ~ 2025-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
629,381 GBP2024-07-01 ~ 2025-06-30
Property, Plant & Equipment
Improvements to leasehold property
402,529 GBP2025-06-30
188,866 GBP2024-06-30
Plant and equipment
1,286,100 GBP2025-06-30
1,657,201 GBP2024-06-30
Motor vehicles
15,374 GBP2025-06-30
0 GBP2024-06-30
Other Investments Other Than Loans
Non-current
1,172,999 GBP2025-06-30
2,237,552 GBP2024-06-30
Amounts invested in assets
Non-current
4,173,009 GBP2025-06-30
4,037,816 GBP2024-06-30
Trade Debtors/Trade Receivables
Current
4,021,035 GBP2025-06-30
4,652,911 GBP2024-06-30
Amount of corporation tax that is recoverable
Current
2,740,306 GBP2025-06-30
2,764,384 GBP2024-06-30
Other Debtors
Current
2,147,334 GBP2025-06-30
2,241,305 GBP2024-06-30
Prepayments/Accrued Income
Current
798,699 GBP2025-06-30
666,746 GBP2024-06-30
Debtors
Current, Amounts falling due within one year
10,602,383 GBP2025-06-30
Amounts falling due within one year, Current
10,848,085 GBP2024-06-30
Bank Borrowings/Overdrafts
Current
1,515,303 GBP2025-06-30
791,578 GBP2024-06-30
Finance Lease Liabilities - Total Present Value
Current
228,793 GBP2025-06-30
222,375 GBP2024-06-30
Trade Creditors/Trade Payables
Current
2,347,331 GBP2025-06-30
2,837,315 GBP2024-06-30
Amounts owed to group undertakings
Current
585,840 GBP2025-06-30
511,646 GBP2024-06-30
Other Creditors
Current
63,243 GBP2025-06-30
83,858 GBP2024-06-30
Accrued Liabilities/Deferred Income
Current
1,287,739 GBP2025-06-30
1,955,683 GBP2024-06-30
Creditors
Current
6,028,249 GBP2025-06-30
6,402,455 GBP2024-06-30
Finance Lease Liabilities - Total Present Value
Non-current
433,607 GBP2025-06-30
668,817 GBP2024-06-30
Bank Overdrafts
1,515,303 GBP2025-06-30
791,578 GBP2024-06-30
Total Borrowings
Current
1,515,303 GBP2025-06-30
791,578 GBP2024-06-30
Minimum gross finance lease payments owing
Amounts falling due within one year
238,770 GBP2025-06-30
222,375 GBP2024-06-30
Minimum gross finance lease payments owing
662,400 GBP2025-06-30
891,192 GBP2024-06-30
Par Value of Share
Class 1 ordinary share
1 GBP2024-07-01 ~ 2025-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
10 shares2025-06-30
10 shares2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
352,011 GBP2025-06-30
387,982 GBP2024-06-30
Between two and five year
3,372,520 GBP2025-06-30
398,021 GBP2024-06-30
More than five year
10,644,319 GBP2025-06-30
63,000 GBP2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
14,368,850 GBP2025-06-30
849,003 GBP2024-06-30
Related profiles found in government register
  • MAC CLINICAL RESEARCH FINANCE LTD
    Info
    Registered number 09518942
    19 Park Road, Lytham St. Annes, Lancashire FY8 1PW
    PRIVATE LIMITED COMPANY incorporated on 2015-03-31 (11 years 1 month). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-10-26
    CIF 0
  • MAC CLINICAL RESEARCH FINANCE LTD
    S
    Registered number 09518942
    19, Park Road, Lytham St. Annes, Lancashire, England, FY8 1PW
    Private Limited Company in Companies House, England
    CIF 1
  • MAC CLINICAL RESEARCH FINANCE LTD
    S
    Registered number 9518942
    19, Park Road, Lytham St. Annes, London, State * *, United Kingdom, FY8 1PW
    Limited Company in Companies House, England
    CIF 2
child relation
Offspring entities and appointments 2
  • 1
    INTELLIGENT CLINICAL LIMITED
    - now SC653007
    RCS NEWCO LIMITED - 2020-06-01
    Ground Floor, Fleming Pavilion Todd Campus, West Of Scotland Science Park, Glasgow, Scotland
    Active Corporate (7 parents)
    Person with significant control
    2024-03-15 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
  • 2
    SMO GROUP LIMITED
    - now 09630154
    MAC GROUP LTD - 2017-02-10
    19 Park Road, Lytham St. Annes, Lancashire, United Kingdom
    Active Corporate (3 parents)
    Person with significant control
    2022-01-10 ~ now
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.